Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages

Tetsuji Nakano1, Kazufumi Hiramatsu, Kenji Kishi

  • 1Second Department of Internal Medicine, Oita Medical University, Hasama, Oita 879-5593, Japan.

Insights

Clindamycin (CLI) affects cytokine production in macrophages stimulated with lipopolysaccharide (LPS). While intracellular levels of certain cytokines change, their mRNA levels remain unaffected, suggesting post-transcriptional modulation by CLI.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Lipopolysaccharide (LPS) is a potent stimulator of immune responses in macrophages.
  • Cytokine induction is a critical component of the inflammatory process.
  • Understanding how antibiotics modulate these responses is crucial for clinical applications.

Purpose of the Study:

  • To investigate the mechanism by which clindamycin (CLI) modulates cytokine induction.
  • To determine the effect of CLI on intracellular cytokine expression and mRNA levels following LPS stimulation.

Main Methods:

  • Macrophage cell cultures were stimulated with LPS.
  • Clindamycin (CLI) was administered to investigate its modulatory effects.
  • Intracellular cytokine expression levels (TNF-alpha, IL-1beta, IL-6) were measured.
  • Cytokine mRNA expression levels were quantified.

Main Results:

  • CLI decreased intracellular expression of tumor necrosis factor alpha and interleukin-1beta.
  • CLI increased intracellular expression of interleukin-6.
  • No significant differences in cytokine mRNA expression levels were observed between CLI-treated and untreated groups.

Conclusions:

  • Clindamycin modulates intracellular cytokine production in LPS-stimulated macrophages.
  • The mechanism of modulation appears to occur post-transcriptionally.
  • These findings highlight a potential immunomodulatory role of clindamycin beyond its antimicrobial activity.

Related Concept Videos